Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mabthera plus CHOP versus CHOP in relapsed follicular non-Hodgkin lymphoma
ISRCTN65655917Phase 3Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Nov 1998
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
01
Overview
Phase 3, randomised, open-label trial of rituximab in follicular lymphoma (FL) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Started Nov 1998; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on ISRCTN65655917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN65655917.